• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性且有高视力丧失风险患者的眼底自发荧光

Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss.

作者信息

Lois Noemi, Owens Sarah L, Coco Rosa, Hopkins Jill, Fitzke Frederick W, Bird Alan C

机构信息

Medical Retinal Service, Moorfields Eye Hospital, London, England.

出版信息

Am J Ophthalmol. 2002 Mar;133(3):341-9. doi: 10.1016/s0002-9394(01)01404-0.

DOI:10.1016/s0002-9394(01)01404-0
PMID:11860971
Abstract

PURPOSE

To describe fundus autofluorescence (AF) patterns and their change over time in patients with age-related macular degeneration (AMD) and high risk of visual loss participating in the drusen laser study (DLS).

DESIGN

Randomized clinical trial.

METHODS

The study population consisted of 29 patients (35 eyes) participating in the DLS, which is a prospective, randomized, controlled clinical trial of prophylactic laser therapy in patients with AMD and high risk of neovascular complications. The intervention consisted of 16 eyes having prophylactic laser and 19 receiving no treatment. The main outcome measures were changes in the distribution of drusen and AF. Patients were reviewed for a median follow-up or 24 months (range 12-36 months).

RESULTS

At baseline, four patterns of fundus AF were recognized: focal increased AF (n = 18), reticular AF (n = 3), combined focal and reticular AF (n = 2), and homogeneous AF (n = 12). At last follow-up, fundus AF remained unchanged in 15 untreated (78%) and in seven treated (43%) eyes. In only one untreated eye, focal areas of increased AF returned to background levels and were no longer detectable at last follow-up, compared with six treated eyes. This difference was statistically significant (P =.03). Only large foveal soft drusen (drusenoid pigment epithelium detachments) consistently corresponded with focal changes in AF, whereas no obvious correspondence was found between small soft drusen located elsewhere and changes in AF.

CONCLUSION

The lack of obvious correspondence between the distribution of drusen and of AF found in this study appears to indicate that drusen and AF represent independent measures of aging in the posterior pole.

摘要

目的

描述参与玻璃膜疣激光研究(DLS)的年龄相关性黄斑变性(AMD)及视力丧失高风险患者的眼底自发荧光(AF)模式及其随时间的变化。

设计

随机临床试验。

方法

研究人群包括参与DLS的29例患者(35只眼),DLS是一项针对有新生血管并发症高风险的AMD患者进行预防性激光治疗的前瞻性、随机、对照临床试验。干预措施包括16只眼接受预防性激光治疗,19只眼未接受治疗。主要观察指标为玻璃膜疣分布和AF的变化。对患者进行了中位随访24个月(范围12 - 36个月)。

结果

基线时,识别出四种眼底AF模式:局灶性AF增强(n = 18)、网状AF(n = 3)、局灶性与网状AF合并(n = 2)以及均匀性AF(n = 12)。在末次随访时,15只未治疗眼(78%)和7只治疗眼(43%)的眼底AF保持不变。与6只治疗眼相比,仅1只未治疗眼的局灶性AF增强区域恢复到背景水平,在末次随访时不再可检测到。这种差异具有统计学意义(P = 0.03)。只有大的黄斑区软性玻璃膜疣(玻璃膜疣样色素上皮脱离)始终与AF的局灶性变化相对应,而位于其他部位的小软性玻璃膜疣与AF变化之间未发现明显对应关系。

结论

本研究中发现的玻璃膜疣分布与AF之间缺乏明显对应关系,似乎表明玻璃膜疣和AF代表了后极部衰老的独立指标。

相似文献

1
Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss.年龄相关性黄斑变性且有高视力丧失风险患者的眼底自发荧光
Am J Ophthalmol. 2002 Mar;133(3):341-9. doi: 10.1016/s0002-9394(01)01404-0.
2
Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration.阈下红外(810纳米)二极管激光黄斑格栅光凝治疗非渗出性年龄相关性黄斑变性后玻璃膜疣减少的预测因素
Am J Ophthalmol. 2002 Oct;134(4):577-85. doi: 10.1016/s0002-9394(02)01691-4.
3
Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.红外(810纳米)二极管激光黄斑格栅光凝术在非渗出性年龄相关性黄斑变性预防性治疗中的疗效:一项随机试验性研究的两年结果
Ophthalmology. 1999 Nov;106(11):2082-90. doi: 10.1016/S0161-6420(99)90487-6.
4
Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.年龄相关性黄斑变性预防试验并发症中脉络膜新生血管形成和地图样萎缩的危险因素。
Ophthalmology. 2008 Sep;115(9):1474-9, 1479.e1-6. doi: 10.1016/j.ophtha.2008.03.008. Epub 2008 May 27.
5
Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration.年龄相关性黄斑变性早期、萎缩性和高危对侧眼的自发荧光特征
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5495-504. doi: 10.1167/iovs.05-1318.
6
Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.年龄相关性黄斑变性及对侧眼脉络膜新生血管发生的危险因素:一项 3 年随访研究。
Ophthalmologica. 2011;226(3):110-8. doi: 10.1159/000329473. Epub 2011 Aug 3.
7
Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression.年龄相关性黄斑变性中的玻璃膜疣:发病机制、自然病程及激光光凝诱导的消退
Surv Ophthalmol. 1999 Jul-Aug;44(1):1-29. doi: 10.1016/s0039-6257(99)00072-7.
8
Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients.年龄相关性黄斑变性的预防性治疗报告第2号:对患有玻璃膜疣的眼睛进行810纳米激光治疗:双侧符合条件的患者。
Ophthalmic Surg Lasers Imaging. 2009 Nov-Dec;40(6):530-8. doi: 10.3928/15428877-20091030-01.
9
Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.年龄相关性黄斑变性的预防性治疗报告第1号:对有玻璃膜疣的眼睛进行810纳米激光治疗。单侧符合条件的患者。
Ophthalmology. 2006 Apr;113(4):622.e1. doi: 10.1016/j.ophtha.2005.10.066.
10
Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.对患有大玻璃膜疣的眼睛进行激光治疗。一项初步随机临床试验的短期效果。脉络膜新生血管预防试验研究组。
Ophthalmology. 1998 Jan;105(1):11-23.

引用本文的文献

1
Blue Light and Green Light Fundus Autofluorescence, Complementary to Optical Coherence Tomography, in Age-Related Macular Degeneration Evaluation.蓝光和绿光眼底自发荧光在年龄相关性黄斑变性评估中对光学相干断层扫描的补充作用
Diagnostics (Basel). 2025 Jul 2;15(13):1688. doi: 10.3390/diagnostics15131688.
2
Assessing Reliability and Agreement in Topographic Measurement of Reticular Pseudodrusen Area: A Multimodal Imaging Approach.评估视网膜色素上皮网状假性玻璃膜疣区域地形测量的可靠性和一致性:一种多模态成像方法。
Retina. 2025 May 7;45(9):1701-11. doi: 10.1097/IAE.0000000000004514.
3
Fluorescence Lifetime and Spectral Characteristics of Subretinal Drusenoid Deposits and Their Predictive Value for Progression of Age-Related Macular Degeneration.
视网膜下硬性脂褐质沉积的荧光寿命和光谱特征及其对年龄相关性黄斑变性进展的预测价值。
Invest Ophthalmol Vis Sci. 2022 Dec 1;63(13):23. doi: 10.1167/iovs.63.13.23.
4
Intraocular iron injection induces oxidative stress followed by elements of geographic atrophy and sympathetic ophthalmia.眼内铁注射诱导氧化应激,随后出现地图状萎缩和交感眼炎的特征。
Aging Cell. 2021 Nov;20(11):e13490. doi: 10.1111/acel.13490. Epub 2021 Oct 9.
5
Progressive Dysmorphia of Retinal Pigment Epithelium in Age-Related Macular Degeneration Investigated by Fluorescence Lifetime Imaging.荧光寿命成像研究年龄相关性黄斑变性中视网膜色素上皮的进行性形态异常。
Invest Ophthalmol Vis Sci. 2021 Sep 2;62(12):2. doi: 10.1167/iovs.62.12.2.
6
The Use of Fundus Autofluorescence in Dry Age-Related Macular Degeneration.眼底自发荧光在干性年龄相关性黄斑变性中的应用。
Turk J Ophthalmol. 2021 Jun 29;51(3):169-176. doi: 10.4274/tjo.galenos.2020.49107.
7
Lipofuscin: a key compound in ophthalmic practice.脂褐素:眼科实践中的关键化合物。
Rom J Ophthalmol. 2021 Apr-Jun;65(2):109-113. doi: 10.22336/rjo.2021.23.
8
Color Fundus Autofluorescence to Determine Activity of Macular Neovascularization in Age-Related Macular Degeneration.眼底自发荧光颜色判断年龄相关性黄斑变性中黄斑新生血管的活动。
Transl Vis Sci Technol. 2021 Feb 5;10(2):33. doi: 10.1167/tvst.10.2.33.
9
Multimodal, multitask, multiattention (M3) deep learning detection of reticular pseudodrusen: Toward automated and accessible classification of age-related macular degeneration.多模态、多任务、多注意力(M3)深度学习检测网状假性脉络膜:实现年龄相关性黄斑变性的自动化和可及性分类。
J Am Med Inform Assoc. 2021 Jun 12;28(6):1135-1148. doi: 10.1093/jamia/ocaa302.
10
Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.视觉循环调节剂与安慰剂或观察用于预防和治疗与年龄相关的黄斑变性引起的地图状萎缩。
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD013154. doi: 10.1002/14651858.CD013154.pub2.